The Unz Review • An Alternative Media Selection$
A Collection of Interesting, Important, and Controversial Perspectives Largely Excluded from the American Mainstream Media
RSS
Show by ⇅ 
 
BlogviewPaul Craig Roberts Archive
/
FDA
 BlogviewPaul Craig Roberts Archive
/
FDA

◄►Bookmark◄❌►▲ ▼Toggle AllToC▲▼Add to LibraryRemove from Library • B
Show CommentNext New CommentNext New ReplyRead More
ReplyAgree/Disagree/Etc. More... This Commenter This Thread Hide Thread Display All Comments
AgreeDisagreeThanksLOLTroll
These buttons register your public Agreement, Disagreement, Thanks, LOL, or Troll with the selected comment. They are ONLY available to recent, frequent commenters who have saved their Name+Email using the 'Remember My Information' checkbox, and may also ONLY be used three times during any eight hour period.
Ignore Commenter Follow Commenter
Ivermectin Is a Proven Cure for Covid. Don’t Let Anyone Tell You Different.
• September 1, 2023
• 600 Words
During the years of the Covid-19 Deception, I reported that Covid was rare in those parts of Africa where Ivermectin was used weekly as a preventative of river blindness and HCQ was used as a preventative of malaria. I also reported that large parts of India used Ivermectin as a preventative and cure and was... Read More
FDA’s Approval of Pfizer Covid Vaccine Is Not Justified
• August 28, 2021
• 300 Words
Surveys show a collapse in confidence of medical professionals in the FDA and CDC. It is completely obvious that the two corrupt government agencies sacrificed public health to pharmaceutical profits. The approval granted Pfizer’s “vaccine” was given far in advance of the necessary studies, and the FDA’s pronouncement that the “vaccine” is effective and safe... Read More
The FDA Has Proved Itself to be A Totally Corrupt and Criminal Organization
• August 25, 2021
• 800 Words
As I predicted, the corrupt US Food & Drug Administration (FDA), allegedly a regulatory agency but in actuality an agent for Big Pharma and agri-business, has, according to news reports, given final approval to Pfizer’s Covid “vaccine.” (Why only Pfizer’s? Is there favoritism at the FDA?) The FDA congratulates itself declaring the “vaccine” a “milestone... Read More
Medical Authorities Continue to Block Effective Covid Treatment
• August 28, 2020
• 300 Words
The conflict of interest between clinical trials of drugs that determine their effectiveness and safety and the pharmaceutical industry that funds most of the trials is astonishing. Yet nothing is done about it. Two-thirds of the Federal Food and Drug Administration’s budget for evaluating prescription drugs comes from the industry that the FDA regulates. In... Read More
"FDA" Items Across Entire Archive
Paul Craig Roberts
About Paul Craig Roberts

Paul Craig Roberts has had careers in scholarship and academia, journalism, public service, and business. He is chairman of The Institute for Political Economy.

Dr. Roberts has held academic appointments at Virginia Tech, Tulane University, University of New Mexico, Stanford University where he was Senior Research Fellow in the Hoover Institution, George Mason University where he had a joint appointment as professor of economics and professor of business administration, and Georgetown University where he held the William E. Simon Chair in Political Economy in the Center for Strategic and International Studies.

Dr. Roberts was associate editor and columnist for The Wall Street Journal and columnist for Business Week and the Scripps Howard News Service. He was a nationally syndicated columnist for Creators Syndicate in Los Angeles. In 1992 he received the Warren Brookes Award for Excellence in Journalism. In 1993 the Forbes Media Guide ranked him as one of the top seven journalists in the United States.

President Reagan appointed Dr. Roberts Assistant Secretary of the Treasury for Economic Policy and he was confirmed in office by the U.S. Senate. From 1975 to 1978, Dr. Roberts served on the congressional staff where he drafted the Kemp-Roth bill and played a leading role in developing bipartisan support for a supply-side economic policy. After leaving the Treasury, he served as a consultant to the U.S. Department of Defense and the U.S. Department of Commerce.